NCT01549496View on ClinicalTrials.gov

A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2012

Conditions
Hepatitis CHypertension
Interventions
DRUG

Amlodipine

amlodipine 2.5 mg QD

DRUG

Diltiazem

diltiazem 120 mg qd

Trial Locations (1)

K1H8L6

Clinical Investigation Unit, Ottawa Hospital Research Institute, Ottawa

Sponsors
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Ottawa Hospital Research Institute

OTHER